BP
MD icon

Ballentine Partners’s Pediatrix Medical MD Stock Holding History

Ballentine Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Hold
17,641
– – 0.01% 606
2026
Q1 		$377K Sell
17,641
-39
-0.2% -$812 0.01% 630
2025
Q4 		$378K Hold
17,680
– – 0.01% 610
2025
Q3 		$296K Hold
17,680
– – ﹤0.01% 718
2025
Q2 		$254K Sell
17,680
-576
-3% -$7.9K ﹤0.01% 767
2025
Q1 		$265K Buy
18,256
+576
+3% +$8.18K ﹤0.01% 673
2024
Q4 		$232K Buy
17,680
+40
+0.2% +$552 ﹤0.01% 721
2024
Q3 		$204K Buy
17,640
+131
+0.7% +$1.24K ﹤0.01% 747
2024
Q2 		$132K Buy
+17,509
New +$145K ﹤0.01% 714

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Ballentine Partners's MD Position: Q2 2026 in Review

Ballentine Partners held its Pediatrix Medical (MD) position steady in Q2 2026 at 17,641 shares worth $447K. The position accounts for 0.01% of the portfolio, ranked #606.

Ballentine Partners first reported a position in MD in Q2 2024 and has held it in 9 quarters since. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Ballentine Partners held 17,641 shares of Pediatrix Medical worth $447K as of Q2 2026.
  • Ballentine Partners left its Pediatrix Medical share count unchanged in Q2 2026.
  • Pediatrix Medical made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #606 holding.
  • Ballentine Partners first reported a position in Pediatrix Medical in Q2 2024 and has held it in 9 quarters since.
  • 305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.